ASX - By Stock
|
IXC |
Re:
Ann: Phase III Clinical Trial Update and New IIH Market Analysis
|
|
SSilverstein
|
224 |
54K |
0 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
224
|
54K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase III Clinical Trial Update and New IIH Market Analysis
|
|
SSilverstein
|
224 |
54K |
8 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
224
|
54K
|
8
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
SSilverstein
|
523 |
95K |
0 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
523
|
95K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase III Clinical Trial Update and New IIH Market Analysis
|
|
SSilverstein
|
224 |
54K |
2 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
224
|
54K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase III Clinical Trial Update and New IIH Market Analysis
|
|
SSilverstein
|
224 |
54K |
0 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
224
|
54K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase III Clinical Trial Update and New IIH Market Analysis
|
|
SSilverstein
|
224 |
54K |
3 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
224
|
54K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase III Clinical Trial Update and New IIH Market Analysis
|
|
SSilverstein
|
224 |
54K |
0 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
224
|
54K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase III Clinical Trial Update and New IIH Market Analysis
|
|
SSilverstein
|
224 |
54K |
0 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
224
|
54K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase III Clinical Trial Update and New IIH Market Analysis
|
|
SSilverstein
|
224 |
54K |
8 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
224
|
54K
|
8
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
SSilverstein
|
523 |
95K |
7 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
523
|
95K
|
7
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase III Clinical Trial Update and New IIH Market Analysis
|
|
SSilverstein
|
224 |
54K |
0 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
224
|
54K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
SSilverstein
|
523 |
95K |
1 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
523
|
95K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
SSilverstein
|
523 |
95K |
2 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
523
|
95K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted European Orphan Drug Designation for TBI
|
|
SSilverstein
|
74 |
17K |
0 |
25/06/23 |
25/06/23 |
ASX - By Stock
|
74
|
17K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Twiggy's Invex Therapeutics | The Imminent Coin Flip
|
|
SSilverstein
|
219 |
45K |
2 |
25/06/23 |
25/06/23 |
ASX - By Stock
|
219
|
45K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted European Orphan Drug Designation for TBI
|
|
SSilverstein
|
74 |
17K |
1 |
25/06/23 |
25/06/23 |
ASX - By Stock
|
74
|
17K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted European Orphan Drug Designation for TBI
|
|
SSilverstein
|
74 |
17K |
0 |
24/06/23 |
24/06/23 |
ASX - By Stock
|
74
|
17K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted European Orphan Drug Designation for TBI
|
|
SSilverstein
|
74 |
17K |
5 |
24/06/23 |
24/06/23 |
ASX - By Stock
|
74
|
17K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted European Orphan Drug Designation for TBI
|
|
SSilverstein
|
74 |
17K |
1 |
24/06/23 |
24/06/23 |
ASX - By Stock
|
74
|
17K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted European Orphan Drug Designation for TBI
|
|
SSilverstein
|
74 |
17K |
0 |
24/06/23 |
24/06/23 |
ASX - By Stock
|
74
|
17K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Fundamental Analysis Discussion Only (IXC Thread)
|
|
SSilverstein
|
40 |
9.4K |
4 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
40
|
9.4K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Fundamental Analysis Discussion Only (IXC Thread)
|
|
SSilverstein
|
40 |
9.4K |
0 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
40
|
9.4K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted European Orphan Drug Designation for TBI
|
|
SSilverstein
|
74 |
17K |
0 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
74
|
17K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
SSilverstein
|
523 |
95K |
5 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
523
|
95K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted European Orphan Drug Designation for TBI
|
|
SSilverstein
|
74 |
17K |
4 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
74
|
17K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
SSilverstein
|
523 |
95K |
1 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
523
|
95K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Fundamental Analysis Discussion Only (IXC Thread)
|
|
SSilverstein
|
40 |
9.4K |
0 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
40
|
9.4K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
SSilverstein
|
523 |
95K |
3 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
523
|
95K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
SSilverstein
|
523 |
95K |
0 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
523
|
95K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Twiggy's Invex Therapeutics | The Imminent Coin Flip
|
|
SSilverstein
|
219 |
45K |
1 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
219
|
45K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Twiggy's Invex Therapeutics | The Imminent Coin Flip
|
|
SSilverstein
|
219 |
45K |
2 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
219
|
45K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
SSilverstein
|
523 |
95K |
0 |
03/06/23 |
03/06/23 |
ASX - By Stock
|
523
|
95K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Twiggy's Invex Therapeutics | The Imminent Coin Flip
|
|
SSilverstein
|
219 |
45K |
5 |
02/06/23 |
02/06/23 |
ASX - By Stock
|
219
|
45K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
Twiggy's Invex Therapeutics | The Imminent Coin Flip
|
|
SSilverstein
|
219 |
45K |
1 |
02/06/23 |
02/06/23 |
ASX - By Stock
|
219
|
45K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
SSilverstein
|
523 |
95K |
2 |
02/06/23 |
02/06/23 |
ASX - By Stock
|
523
|
95K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
SSilverstein
|
523 |
95K |
3 |
02/06/23 |
02/06/23 |
ASX - By Stock
|
523
|
95K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
SSilverstein
|
523 |
95K |
3 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
523
|
95K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
SSilverstein
|
523 |
95K |
0 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
523
|
95K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
SSilverstein
|
523 |
95K |
1 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
523
|
95K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Twiggy's Invex Therapeutics | The Imminent Coin Flip
|
|
SSilverstein
|
219 |
45K |
0 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
219
|
45K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
SSilverstein
|
523 |
95K |
1 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
523
|
95K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
SSilverstein
|
523 |
95K |
0 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
523
|
95K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
SSilverstein
|
523 |
95K |
1 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
523
|
95K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
SSilverstein
|
523 |
95K |
1 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
523
|
95K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
SSilverstein
|
523 |
95K |
2 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
523
|
95K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Twiggy's Invex Therapeutics | The Imminent Coin Flip
|
|
SSilverstein
|
219 |
45K |
1 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
219
|
45K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Twiggy's Invex Therapeutics | The Imminent Coin Flip
|
|
SSilverstein
|
219 |
45K |
1 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
219
|
45K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Twiggy's Invex Therapeutics | The Imminent Coin Flip
|
|
SSilverstein
|
219 |
45K |
0 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
219
|
45K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Twiggy's Invex Therapeutics | The Imminent Coin Flip
|
|
SSilverstein
|
219 |
45K |
1 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
219
|
45K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Twiggy's Invex Therapeutics | The Imminent Coin Flip
|
|
SSilverstein
|
219 |
45K |
1 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
219
|
45K
|
1
|
|